Deferred Tax Assets, Gross of Vitro Biopharma, Inc. from 31 Oct 2012 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Vitro Biopharma, Inc. quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Oct 2012 to 31 Oct 2025.
  • Vitro Biopharma, Inc. Deferred Tax Assets, Gross for the quarter ending 31 Oct 2025 was $9,840,000, a 32% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $9,840,000 +$2,403,000 +32% 31 Oct 2025 10-K 13 Feb 2026 2025 FY
Q3 2024 $7,437,000 +$2,389,000 +47% 31 Oct 2024 10-K 13 Feb 2026 2025 FY
Q3 2023 $5,048,000 +$1,341,000 +36% 31 Oct 2023 10-K 28 Jan 2025 2024 FY
Q3 2022 $3,707,000 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q3 2015 $1,256,952 +$82,223 +7% 31 Oct 2015 10-K 22 Sep 2016 2015 FY
Q3 2014 $1,174,729 -$894,170 -43% 31 Oct 2014 10-K 22 Sep 2016 2015 FY
Q3 2013 $2,068,899 +$49,557 +2.5% 31 Oct 2013 10-Q 30 Mar 2016 2015 Q3
Q3 2012 $2,019,342 31 Oct 2012 10-Q 22 Sep 2014 2014 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.